Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation

  • Wallis C.Y. Lau
    UCL School of Pharmacy, London, United Kingdom, and Centre for Safe Medication and Practice Research, The University of Hong Kong, Hong Kong, China (W.C.L., K.K.M.)
  • Ching-Lung Cheung
    Centre for Safe Medication and Practice Research, The University of Hong Kong, Hong Kong, China (C.C., E.W.C., C.W.S.)
  • Kenneth K.C. Man
    UCL School of Pharmacy, London, United Kingdom, and Centre for Safe Medication and Practice Research, The University of Hong Kong, Hong Kong, China (W.C.L., K.K.M.)
  • Esther W. Chan
    Centre for Safe Medication and Practice Research, The University of Hong Kong, Hong Kong, China (C.C., E.W.C., C.W.S.)
  • Chor Wing Sing
    Centre for Safe Medication and Practice Research, The University of Hong Kong, Hong Kong, China (C.C., E.W.C., C.W.S.)
  • Gregory Y.H. Lip
    Liverpool Centre for Cardiovascular Science, University of Liverpool, and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom, and Aalborg Thrombosis Research Unit, Aalborg University, Aalborg, Denmark (G.Y.L.)
  • Chung-Wah Siu
    Queen Mary Hospital, The University of Hong Kong, Hong Kong, China (C.S.)
  • Joanne K.Y. Lam
    Osteoporosis Centre, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China (J.K.L., A.C.L.)
  • Alan C.H. Lee
    Osteoporosis Centre, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China (J.K.L., A.C.L.)
  • Ian C.K. Wong
    UCL School of Pharmacy, London, United Kingdom, Centre for Safe Medication and Practice Research, The University of Hong Kong, Hong Kong, and The University of Hong Kong Shenzhen Hospital, Shenzhen, Guangdong, China (I.C.W.)

書誌事項

タイトル別名
  • A Population-Based Cohort Study

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1362825893969054208
  • DOI
    10.7326/m19-3671
  • ISSN
    15393704
    00034819
  • データソース種別
    • Crossref

問題の指摘

ページトップへ